Posted Jan 2, 2018 Longevity Biotech Awarded $225K Phase I SBIR Contract From NHLBI/NIH to Develop 5A apoA-I Mimetic Peptide for Treatment of Severe Asthma
Posted Dec 27, 2017 Great to see mass media running a story about computational design of denovo synthetic peptides! David Baker et. al. do some very interesting work. Also great to see one of SAB members William DeGrado in the article as well! FYI: Hybridtides are synthetic, designer peptides. Happy holidays to all!
Posted Dec 12, 2017 Holiday cookies in the break room! Come and get 'em....
Posted Nov 27, 2017 We are looking for the next scientific rockstar to join our team and help develop the next generation of breakthrough therapeutics. Share / tell your friends... you can apply directly here -->
Posted Nov 9, 2017 Thanks MS News Today for highlighting our MS program. We are very excited to move this program forward with the support of National Multiple Sclerosis Society!
Posted Oct 27, 2017 We are pleased to announce that we recently received funding from the National Multiple Sclerosis Society to evaluate LBT-3627 for MS! Way to go team... now the real work begins. Hope we can make a real difference in patients lives!
Posted Aug 14, 2017 Been a busy summer here at Longevity Biotech. Check out this recent commentary in The Lancet regarding autoimmunity and Parkinson's Disease from our friends at University of Nebraska Medical Center - UNMC (17)30276-4/abstract Bottom line is that there is still more work to be done, contact us for more information!